In the Original Investigation titled “Identification and Validation of Plasma Metabolomic Signatures in Precancerous Gastric Lesions That Progress to Cancer,”1 published June 22, 2021, there were errors in a column of 95% CI values in Table 1. The odds ratios were correct, but each 95% CI given in the OR (95% CI) column under the IM/LGIN vs SG/CAG heading within the Validation set section was incorrect. This article has been corrected.1
Reference
- 1.Huang S, Guo Y, Li ZW, et al. Identification and validation of plasma metabolomic signatures in precancerous gastric lesions that progress to cancer. JAMA Netw Open. 2021;4(6):e2114186. doi: 10.1001/jamanetworkopen.2021.14186 [DOI] [PMC free article] [PubMed] [Google Scholar]